0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.45%
Negative revenue growth while 0376.HK stands at 11.73%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-61.53%
Negative gross profit growth while 0376.HK is at 11.73%. Joel Greenblatt would examine cost competitiveness or demand decline.
-496.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-496.72%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-64.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-27.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-27.12%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
29.22%
Slight or no buybacks while 0376.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
29.28%
Slight or no buyback while 0376.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while 0376.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.10%
Negative OCF growth while 0376.HK is at 45.84%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.79%
Negative FCF growth while 0376.HK is at 45.88%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-48.70%
Negative 10Y revenue/share CAGR while 0376.HK stands at 371.95%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-49.30%
Negative 5Y CAGR while 0376.HK stands at 560.96%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-53.69%
Negative 3Y CAGR while 0376.HK stands at 6482.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-963.10%
Negative 10Y OCF/share CAGR while 0376.HK stands at 461.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-956.34%
Negative 5Y OCF/share CAGR while 0376.HK is at 47.53%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.05%
Negative 3Y OCF/share CAGR while 0376.HK stands at 1708.37%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-208.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-514.36%
Negative 5Y net income/share CAGR while 0376.HK is 129.73%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-282.74%
Negative 3Y CAGR while 0376.HK is 134.82%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
135.21%
10Y equity/share CAGR at 50-75% of 0376.HK's 189.79%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-6.80%
Negative 5Y equity/share growth while 0376.HK is at 49.07%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.90%
Negative 3Y equity/share growth while 0376.HK is at 81.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0376.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0376.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0376.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-5.13%
Firm’s AR is declining while 0376.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
22.07%
Inventory growth of 22.07% while 0376.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
9.37%
Asset growth above 1.5x 0376.HK's 4.78%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-26.90%
We have a declining book value while 0376.HK shows 2.25%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
73.53%
Debt growth far above 0376.HK's 15.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-37.45%
Our R&D shrinks while 0376.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-33.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.